Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus. [electronic resource]
Producer: 20030819Description: 1880-8 p. digitalISSN:- 1046-6673
- Adult
- Aged
- Analysis of Variance
- Apolipoproteins B -- blood
- Blood Glucose -- metabolism
- Blood Pressure
- Body Weight
- Cardiovascular System -- drug effects
- Cholesterol -- metabolism
- Cyclosporine -- therapeutic use
- Female
- Fibrinogen -- metabolism
- Fibrinolysis
- Graft Survival
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney -- drug effects
- Kidney Transplantation
- Lipoproteins, LDL -- metabolism
- Male
- Middle Aged
- Oxygen -- metabolism
- Risk Factors
- Tacrolimus -- therapeutic use
- Time Factors
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.